無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

欧州の整形外科用バイオマテリアル市場の分析

Europe Market Report Suite for Orthopedic Biomaterials 2017 - MedSuite

発行 iData Research Inc. 商品コード 601886
出版日 ページ情報 英文 877 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.61円で換算しております。

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

Back to Top
欧州の整形外科用バイオマテリアル市場の分析 Europe Market Report Suite for Orthopedic Biomaterials 2017 - MedSuite
出版日: 2017年05月01日 ページ情報: 英文 877 Pages
概要

当レポートでは、欧州の整形外科用バイオマテリアル市場について調査分析し、市場分析 (販売台数、ASP、市場金額・成長率の動向) 、市場促進要因・阻害要因、競合分析、最近のM&Aなど、体系的な情報を提供しています。

エグゼクティブサマリー

欧州の整形外科用バイオマテリアル市場の概要

競合分析

市場動向

市場の発展

対象市場

主な調査アップデート

バージョン履歴

第1章 調査手法

第2章 国別プロファイル

  • イントロダクション
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ベネルクス諸国
  • 北欧諸国
  • オーストリア
  • スイス
  • ポルトガル

第3章 欧州の整形外科用バイオマテリアル市場の概要

  • イントロダクション
  • 為替レート
  • 市場概要
  • 動向分析:セグメント別
  • 促進要因・阻害要因
    • 市場促進要因
    • 市場阻害要因
  • 競合市場シェア分析
  • M&A

第4章 処置件数

  • 処置の定義
  • 骨移植の処置件数:タイプ別
  • 代用骨移植 (BGS) の処置件数
  • 増殖因子 (GF) 骨移植の処置件数
  • 細胞療法の治療件数
  • ヒアルロン酸 (HA) の治療件数:タイプ別
  • 軟骨修復の処置件数:タイプ別
  • 機械加工による脊椎用同種骨移植の処置件数:アプローチ別

第5章 代用骨移植 (BGS) 市場

  • イントロダクション
  • 市場概要
  • 市場分析と予測
  • 促進要因・阻害要因
    • 市場促進要因
    • 市場阻害要因
  • 競合市場シェア分析

第6章 ヒアルロン酸 (HA) 関節内補充療法市場

  • イントロダクション
  • 市場概要
  • 市場分析と予測
  • 促進要因・阻害要因
    • 市場促進要因
    • 市場阻害要因
  • 競合市場シェア分析

第7章 骨形成タンパク質 (BMP) 成長因子療法市場

  • イントロダクション
  • 市場分析と予測
  • 促進要因・阻害要因
    • 市場促進要因
    • 市場阻害要因
  • 競合市場シェア分析

第8章 自家培養軟骨細胞移植 (ACI) 市場

  • イントロダクション
  • 市場分析と予測
  • 促進要因・阻害要因
    • 市場促進要因
    • 市場阻害要因
  • 競合市場シェア分析

第9章 整形外科用細胞療法市場

  • イントロダクション
  • 市場概要
  • 市場分析と予測
  • 促進要因・阻害要因
    • 市場促進要因
    • 市場阻害要因
  • 競合市場シェア分析

略語

目次
Product Code: iDATA_EUOB17_MS

The full report suite on the U.S.European market for orthopedic biomaterials includes bone graft substitutes, which is represented by allografts, demineralized bone matrix and synthetic bone graft market. The report also includes hyaluronic acid viscosupplementation, orthopedic growth factors, orthopedic cell therapy, orthopedic cartilage repair and spinal machined bone allograft markets.

General Report Contents

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions

Lack of reimbursements can limit the European orthopedic biomaterials market. When a product is reimbursed, it is more readily adopted. For instance, in the hyaluronic acid market, most products are classified as medical devices and thus are not eligible for reimbursement. Only a few premium products under the umbrella of pharmaceuticals are reimbursed by the government or healthcare organizations. In addition to not being as well received as reimbursed products, the lack of reimbursement drives pricing down in an effort to make them more affordable. This price deterioration will have a negative impact on the market, as it may not be economically feasible for certain competitors to penetrate a market with low ASPs.

Unlike donated material, synthetic bone graft materials do not carry the risk of disease transmission, nor will they generate an immunogenic response in the recipient. As with allograft, the use of synthetic materials avoids the need for a second bone harvesting procedure. These products have been steadily reducing the amount of autograft bone that doctors have been using. Popularity of synthetics due to the affordability and easy accessibility, synthetic products are becoming the preferred products over allografts, DBMs and autografts. A wide range of synthetic products can offer flexibility and variety for different groups of patients. People in general are becoming more knowledgeable and accepting of synthetic products.

Table of Contents

LIST OF FIGURES VII

LIST OF CHARTS XX

EXECUTIVE SUMMARY 23

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 23

COMPETITIVE ANALYSIS 26

MARKET TRENDS 28

MARKET DEVELOPMENTS 29

MARKETS INCLUDED 30

KEY REPORT UPDATES 31

VERSION HISTORY 32

RESEARCH METHODOLOGY 33

  • 1.1 RESEARCH SCOPE 33
  • 1.2 IDATA'S 9-STEP METHODOLOGY 33
    • Step 1: Project Initiation & Team Selection 33
    • Step 2: Prepare Data Systems and Perform Secondary Research 35
    • Step 3: Preparation for Interviews & Questionnaire Design 36
    • Step 4: Performing Primary Research 37
    • Step 5: Research Analysis: Establishing Baseline Estimates 39
    • Step 6: Market Forecast and Analysis 40
    • Step 7: Identify Strategic Opportunities 42
    • Step 8: Final Review and Market Release 43
    • Step 9: Customer Feedback and Market Monitoring 44

COUNTRY PROFILES 45

  • 2.1 INTRODUCTION 45
  • 2.2 GERMANY 46
  • 2.3 FRANCE 47
  • 2.4 UNITED KINGDOM 48
  • 2.5 ITALY 49
  • 2.6 SPAIN 50
  • 2.7 BENELUX 51
  • 2.8 SCANDINAVIA 52
  • 2.9 AUSTRIA 53
  • 2.10 SWITZERLAND 54
  • 2.11 PORTUGAL 55

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 56

  • 3.1 INTRODUCTION 56
    • 3.1.1 Bone Graft Substitutes 57
    • 3.1.2 Growth Factors 57
    • 3.1.3 Hyaluronic Acid Viscosupplementation 57
    • 3.1.4 Autologous Chondrocyte Implantation 58
    • 3.1.5 Cell Therapies 58
  • 3.2 CURRENCY EXCHANGE RATE 58
  • 3.3 MARKET OVERVIEW 60
  • 3.4 TREND ANALYSIS BY SEGMENT 66
  • 3.5 DRIVERS AND LIMITERS 70
    • 3.5.1 Market Drivers 70
    • 3.5.2 Market Limiters 71
  • 3.6 COMPETITIVE MARKET SHARE ANALYSIS 73
  • 3.7 MERGERS AND ACQUISITIONS 76

PROCEDURE NUMBERS 80

  • 4.1 PROCEDURE DEFINITIONS 80
  • 4.2 BONE GRAFT PROCEDURE NUMBERS BY TYPE 81
  • 4.3 BONE GRAFT SUBSTITUTE PROCEDURE NUMBERS 85
    • 4.3.1 By Material 86
    • 4.3.2 By Indication 89
  • 4.4 GROWTH FACTOR BONE GRAFT PROCEDURE NUMBERS 93
  • 4.5 CELL THERAPY TREATMENT NUMBERS 96
    • 4.5.1 Overview by Type 96
    • 4.5.2 Platelet-Rich Treatment Numbers by Indication 100
    • 4.5.3 Platelet-Rich Treatment Numbers by Indication 103
  • 4.6 HYALURONIC ACID TREATMENT NUMBERS BY TYPE 106
  • 4.7 CARTILAGE REPAIR PROCEDURE NUMBERS BY TYPE 110
  • 4.8 SPINAL MACHINED BONE ALLOGRAFT PROCEDURE NUMBERS BY APPROACH 115

BONE GRAFT SUBSTITUTES MARKET 119

  • 5.1 INTRODUCTION 119
    • 5.1.1 Units per Procedure by Indication 120
  • 5.2 MARKET OVERVIEW 123
    • 5.2.1 Bone Graft Substitute Market by Material 123
    • 5.2.2 Bone Graft Substitute Market by Indication 127
  • 5.3 MARKET ANALYSIS AND FORECAST 131
    • 5.3.1 Total Bone Graft Substitute Market 131
    • 5.3.2 Total Allograft Bone Graft Substitute Market 138
      • 5.3.2.1 Total Allograft Spine Market 146
      • 5.3.2.1.1 Allograft Cervical Spine Market 153
      • 5.3.2.1.2 Allograft Thoracolumbar Spine Market 160
      • 5.3.2.2 Allograft Trauma and Reconstruction Market 167
      • 5.3.2.3 Allograft Craniomaxillofacial Market 174
    • 5.3.3 Total Synthetic Bone Graft Substitute Market 181
      • 5.3.3.1 Total Synthetic Spine Market 189
      • 5.3.3.1.1 Synthetic Cervical Spine Market 197
      • 5.3.3.1.2 Synthetic Thoracolumbar Spine Market 204
      • 5.3.3.2 Synthetic Trauma and Reconstruction Market 211
      • 5.3.3.3 Synthetic Craniomaxillofacial Market 218
    • 5.3.4 Total Demineralized Bone Graft Substitute Bone Matrix Market 225
      • 5.3.4.1 Total Demineralized Bone Matrix Spine Market 233
      • 5.3.4.1.1 Demineralized Bone Matrix Cervical Spine Market 240
      • 5.3.4.1.2 Demineralized Bone Matrix Thoracolumbar Spine Market 247
      • 5.3.4.2 Demineralized Bone Matrix Trauma and Reconstruction Market 254
      • 5.3.4.3 Demineralized Bone Matrix Craniomaxillofacial Market 261
  • 5.4 DRIVERS AND LIMITERS 268
    • 5.4.1 Market Drivers 268
    • 5.4.2 Market Limiters 269
  • 5.5 COMPETITIVE MARKET SHARE ANALYSIS 272

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 277

  • 6.1 INTRODUCTION 277
    • 6.1.1 Benefits of Viscosupplementation 278
    • 6.1.2 Synovial Fluid 278
    • 6.1.3 Treatment Types 279
  • 6.2 MARKET OVERVIEW 280
  • 6.3 MARKET ANALYSIS AND FORECAST 284
    • 6.3.1 Total Hyaluronic Acid Viscosupplementation Market 284
      • 6.3.1.1 Single-Injection Market 292
      • 6.3.1.2 Three-Injection Market 300
      • 6.3.1.3 Five-Injection Market 308
  • 6.4 DRIVERS AND LIMITERS 316
    • 6.4.1 Market Drivers 316
    • 6.4.2 Market Limiters 317
  • 6.5 COMPETITIVE MARKET SHARE ANALYSIS 319

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET 323

  • 7.1 INTRODUCTION 323
  • 7.2 MARKET ANALYSIS AND FORECAST 325
  • 7.3 DRIVERS AND LIMITERS 333
      • 7.3.1.1 Market Drivers 333
      • 7.3.1.2 Market Limiters 333
  • 7.4 COMPETITIVE MARKET SHARE ANALYSIS 335

AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET 338

  • 8.1 INTRODUCTION 338
    • 8.1.1 339
  • 8.2 MARKET ANALYSIS AND FORECAST 341
  • 8.3 DRIVERS AND LIMITERS 349
      • 8.3.1.1 Market Drivers 349
      • 8.3.1.2 Market Limiters 350
  • 8.4 COMPETITIVE MARKET SHARE ANALYSIS 352

ORTHOPEDIC CELL THERAPY MARKET 355

  • 9.1 USA INTRODUCTION 355
  • 9.2 MARKET OVERVIEW 359
  • 9.3 MARKET ANALYSIS AND FORECAST 363
    • 9.3.1 Total Orthopedic Cell Therapy Market 363
    • 9.3.2 Total Platelet-Rich Plasma Market 370
      • 9.3.2.1 Soft Tissue Platelet-Rich Plasma Market 377
      • 9.3.2.2 Orthopedic Platelet-Rich Plasma Market 384
      • 9.3.2.3 Cardiac Platelet-Rich Plasma Market 391
      • 9.3.2.4 Spine Platelet-Rich Plasma Market 398
      • 9.3.2.5 Plastics Platelet-Rich Plasma Market 405
    • 9.3.3 Total Bone Marrow Concentrate Market 412
      • 9.3.3.1 Spine Bone Marrow Concentrate Market 419
      • 9.3.3.2 Trauma Bone Marrow Concentrate Market 426
      • 9.3.3.3 Soft Tissue Concentrated Bone Marrow Aspirate Market 433
      • 9.3.3.4 Joint Concentration Bone Marrow Concentrate Market 440
  • 9.4 DRIVERS AND LIMITERS 447
    • 9.4.1 Market Drivers 447
    • 9.4.2 Market Limiters 448
  • 9.5 COMPETITIVE MARKET SHARE ANALYSIS 450

ABBREVIATIONS 453

LIST OF CHARTS

  • Chart 1 1: Orthopedic Biomaterials Market by Segment, Europe, 2013 - 2023 23
  • Chart 1 2: Orthopedic Biomaterials Market Overview, Europe, 2013 &2023 23
  • Chart 2 1: Country Profile, Germany, 2016 43
  • Chart 2 2: Country Profile, France, 2016 44
  • Chart 2 3: Country Profile, United Kingdom, 2016 45
  • Chart 2 4: Country Profile, Italy, 2016 46
  • Chart 2 5: Country Profile, Spain, 2016 47
  • Chart 2 6: Country Profile, Benelux, 2016 48
  • Chart 2 7: Country Profile, Scandinavia, 2016 49
  • Chart 2 8: Country Profile, Austria, 2016 50
  • Chart 2 9: Country Profile, Switzerland, 2016 51
  • Chart 2 10: Country Profile, Portugal, 2016 52
  • Chart 3 1: Orthopedic Biomaterials Market by Segment, Europe, 2013 - 2023 58
  • Chart 3 2: Orthopedic Biomaterials Market Breakdown, Europe, 2016 59
  • Chart 3 3: Orthopedic Biomaterials Market Breakdown, Europe, 2023 59
  • Chart 3 4: Growth Rates by Segment, Orthopedic Biomaterials Market, Europe, 2013 - 2023 62
  • Chart 3 5: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2016 67
  • Chart 4 1: Bone Graft Procedure Numbers by Type, Europe, 2013 - 2023 71
  • Chart 4 2: Bone Graft Substitute Procedure Numbers by Material, Europe, 2013 - 2023 77
  • Chart 4 3: Bone Graft Substitute Procedure Numbers by Indication, Europe, 2013 - 2023 81
  • Chart 4 4: Growth Factor Bone Graft Procedure Numbers, Europe, 2013 - 2023 83
  • Chart 4 5: Stem Cell Bone Graft Procedure Numbers, Europe, 2013 - 2023 86
  • Chart 4 6: Cell Therapy Treatment Numbers by Type, Europe, 2013 - 2023 89
  • Chart 4 7: Platelet-Rich Plasma Treatment Numbers by Indication, Europe, 2013 - 2023 93
  • Chart 4 8: Bone Marrow Concentrate Treatment Numbers by Indication, Europe, 2013 - 2023 96
  • Chart 4 9: Hyaluronic Acid Treatment Numbers by Type, Europe, 2013 - 2023 99
  • Chart 4 10: Cartilage Repair Procedure Numbers by Type, Europe, 2013 - 2023 103
  • Chart 4 11: Spinal Machined Bone Allograft Procedure Numbers by Approach, Europe, 2013 - 2023 107
  • Chart 5 1: Bone Graft Substitute Market by Indication, Europe, 2013 - 2023 112
  • Chart 5 2: Bone Graft Substitute Market Breakdown by Indication, Europe, 2016 113
  • Chart 5 3: Bone Graft Substitute Market Breakdown by Indication, Europe, 2023 113
  • Chart 5 4: Bone Graft Substitute Market by Segment, Europe, 2013 - 2023 116
  • Chart 5 5: Bone Graft Substitute Market Breakdown by Segment, Europe, 2016 117
  • Chart 5 6: Bone Graft Substitute Market Breakdown by Segment, Europe, 2023 117
  • Chart 5 7: Total Bone Graft Substitute Market, Europe, 2013 - 2023 119
  • Chart 5 8: Total Allograft Market, Europe, 2013 - 2023 126
  • Chart 5 9: Total Allograft Spine Market, Europe, 2013 - 2023 133
  • Chart 5 10: Allograft Cervical Spine Market, Europe, 2013 - 2023 140
  • Chart 5 11: Allograft Thoracolumbar Spine Market, Europe, 2013 - 2023 147
  • Chart 5 12: Allograft Trauma and Reconstruction Market, Europe, 2013 - 2023 154
  • Chart 5 13: Allograft Craniomaxillofacial Market, Europe, 2013 - 2023 161
  • Chart 5 14: Total Synthetic Market, Europe, 2013 - 2023 168
  • Chart 5 15: Total Synthetic Spine Market, Europe, 2013 - 2023 175
  • Chart 5 16: Synthetic Cervical Spine Market, Europe, 2013 - 2023 182
  • Chart 5 17: Synthetic Thoracolumbar Spine Market, Europe, 2013 - 2023 189
  • Chart 5 18: Synthetic Trauma and Reconstruction Market, Europe, 2013 - 2023 196
  • Chart 5 19: Synthetic Craniomaxillofacial Market, Europe, 2013 - 2023 203
  • Chart 5 20: Total Demineralized Bone Matrix Market, Europe, 2013 - 2023 210
  • Chart 5 21: Total Demineralized Bone Matrix Spine Market, Europe, 2013 - 2023 217
  • Chart 5 22: Demineralized Bone Matrix Cervical Spine Market, Europe, 2013 - 2023 224
  • Chart 5 23: Demineralized Bone Matrix Thoracolumbar Spine Market, Europe, 2013 - 2023 231
  • Chart 5 24: Demineralized Bone Matrix Trauma and Reconstruction Market, Europe, 2013 - 2023 238
  • Chart 5 25: Demineralized Bone Matrix Craniomaxillofacial Market, Europe, 2013 - 2023 245
  • Chart 5 26: Leading Competitors, Bone Graft Substitute Market, Europe, 2016 254
  • Chart 6 1: Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2013 - 2023 258
  • Chart 6 2: Hyaluronic Acid Viscosupplementation Market Breakdown, Europe, 2016 259
  • Chart 6 3: Hyaluronic Acid Viscosupplementation Market Breakdown, Europe, 2023 259
  • Chart 6 4: Total Hyaluronic Acid Viscosupplementation Market, Europe, 2013 - 2023 261
  • Chart 6 5: Single-Injection Market, Europe, 2013 - 2023 268
  • Chart 6 6: Three-Injection Market, Europe, 2013 - 2023 275
  • Chart 6 7: Five-Injection Market, Europe, 2013 - 2023 282
  • Chart 6 8: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Europe, 2016 291
  • Chart 7 1: Bone Morphogenetic Protein Growth Factor Therapy Market, Europe, 2013 - 2023 294
  • Chart 7 2: Leading Competitors, Bone Morphogenetic Protein Growth Factor Therapy Market, Europe, 2016 302
  • Chart 8 1: Autologous Chondrocyte Implantation Market, Europe, 2013 - 2023 305
  • Chart 8 2: Leading Competitors, Autologous Chondrocyte Implantation Market, Europe, 2016 313
  • Chart 9 1: Orthopedic Cell Therapy Market by Segment, Europe, 2013 - 2023 317
  • Chart 9 2: Orthopedic Cell Therapy Market Breakdown, Europe, 2016 318
  • Chart 9 3: Orthopedic Cell Therapy Market Breakdown, Europe, 2023 318
  • Chart 9 4: Total Orthopedic Cell Therapy Market, Europe, 2013 - 2023 320
  • Chart 9 5: Total Platelet-Rich Plasma Market, Europe, 2013 - 2023 327
  • Chart 9 6: Soft Tissue Platelet-Rich Plasma Market, Europe, 2013 - 2023 334
  • Chart 9 7: Orthopedic Platelet-Rich Plasma Market, Europe, 2013 - 2023 341
  • Chart 9 8: Cardiac Platelet-Rich Plasma Market, Europe, 2013 - 2023 348
  • Chart 9 9: Spine Platelet-Rich Plasma Market, Europe, 2013 - 2023 355
  • Chart 9 10: Plastics Platelet-Rich Plasma Market, Europe, 2013 - 2023 362
  • Chart 9 11: Total Bone Marrow Concentrate Market, Europe, 2013 - 2023 369
  • Chart 9 12: Spine Bone Marrow Concentrate Market, Europe, 2013 - 2023 376
  • Chart 9 13: Trauma Bone Marrow Concentrate Market, Europe, 2013 - 2023 383
  • Chart 9 14: Soft Tissue Concentrated Bone Marrow Aspirate Market, Europe, 2013 - 2023 390
  • Chart 9 15: Joint Concentration Bone Marrow Concentrate Market, Europe, 2013 - 2023 397
  • Chart 9 16: Leading Competitors, Orthopedic Cell Therapy Market, Europe, 2016 406

LIST OF FIGURES

  • Figure 1 1: Orthopedic Biomaterials Market Share Ranking by Segment, Europe, 2016 26
  • Figure 1 2: Companies Researched in this Report, Europe, 2016 27
  • Figure 1 3: Factors Impacting the Orthopedic Biomaterials Market by Segment, Europe 28
  • Figure 1 4: Recent Events in the Orthopedic Biomaterials Market, Europe, 2013 - 2016 29
  • Figure 1 5: Orthopedic Biomaterials Markets Covered, Europe, 2016 30
  • Figure 1 6: Key Report Updates 31
  • Figure 1 7: Version History 32
  • Figure 3 1: Currency Exchange Rate, 2016 58
  • Figure 3 2: Total Orthopedic Biomaterials Market, Europe, 2013 - 2023 (€M) 60
  • Figure 3 3: Total Orthopedic Biomaterials Market, Europe, 2013 - 2023 (US$M) 61
  • Figure 3 4: Orthopedic Biomaterials Market by Segment, Europe, 2013 - 2023 (€M) 62
  • Figure 3 5: Orthopedic Biomaterials Market by Segment, Europe, 2013 - 2023 (US$M) 63
  • Figure 3 6: Orthopedic Biomaterials Market Growth by Segment, Europe, 2013 - 2023 68
  • Figure 3 7: Drivers and Limiters, Orthopedic Biomaterials Market, Europe, 2016 72
  • Figure 3 8: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2016 79
  • Figure 4 1: Bone Graft Procedure Numbers by Type, Europe, 2013 - 2023 83
  • Figure 4 2: Procedures by Country, Bone Graft Market, Europe, 2013 - 2023 86
  • Figure 4 3: Procedures by Country, Bone Graft Substitutes Market, Europe, 2013 - 2023 87
  • Figure 4 4: Bone Graft Substitute Procedure Numbers by Material, Europe, 2013 - 2023 89
  • Figure 4 5: Bone Graft Substitute Procedure Numbers by Indication, Europe, 2013 - 2023 (1 of 2) 92
  • Figure 4 6: Bone Graft Substitute Procedure Numbers by Indication, Europe, 2013 - 2023 (2 of 2) 93
  • Figure 4 7: Growth Factor Bone Graft Procedure Numbers, Europe, 2013 - 2023 95
  • Figure 4 8: Procedures by Country, Growth Factor Market, Europe, 2013 - 2023 97
  • Figure 4 11: Cell Therapy Treatment Numbers by Type, Europe, 2013 - 2023 98
  • Figure 4 12: Procedures by Country, Cell Therapy Market, Europe, 2013 - 2023 101
  • Figure 4 13: Platelet-Rich Plasma Treatment Numbers by Indication, Europe, 2013 - 2023 103
  • Figure 4 14: Bone Marrow Concentrate Treatment Numbers by Indication, Europe, 2013 - 2023 106
  • Figure 4 15: Hyaluronic Acid Treatment Numbers by Type, Europe, 2013 - 2023 109
  • Figure 4 16: Procedures by Country, Hyaluronic Acid Viscosupplementation Market, Europe, 2013 - 2023 111
  • Figure 4 17: Cartilage Repair Procedure Numbers by Type, Europe, 2013 - 2023 114
  • Figure 4 18: Procedures by Country, Cartilage Repair Market, Europe, 2013 - 2023 116
  • Figure 4 19: Spinal Machined Bone Allograft Procedure Numbers by Approach, Europe, 2013 - 2023 118
  • Figure 4 20: Procedures by Country, Spinal Machined Bone Allograft Market, Europe, 2013 - 2023 120
  • Figure 5 1: Units per Procedure by Indication, Bone Graft Substitute Market, Europe, 2013 - 2023 122
  • Figure 5 3: Bone Graft Substitute Market by Segment, Europe, 2013 - 2023 (€M) 126
  • Figure 5 4: Bone Graft Substitute Market by Segment, Europe, 2013 - 2023 (US$M) 126
  • Figure 5 1: Bone Graft Substitute Market by Indication, Europe, 2013 - 2023 (€M) 130
  • Figure 5 2: Bone Graft Substitute Market by Indication, Europe, 2013 - 2023 (US$M) 130
  • Figure 5 5: Total Bone Graft Substitute Market, Europe, 2013 - 2023 133
  • Figure 5 6: Units Sold by Country, Total Bone Graft Substitute Market, Europe, 2013 - 2023 135
  • Figure 5 7: Average Selling Price by Country, Total Bone Graft Substitute Market, Europe, 2013 - 2023 (€) 136
  • Figure 5 8: Average Selling Price by Country, Total Bone Graft Substitute Market, Europe, 2013 - 2023 (US$) 137
  • Figure 5 9: Market Value by Country, Total Bone Graft Substitute Market, Europe, 2013 - 2023 (€M) 138
  • Figure 5 10: Market Value by Country, Total Bone Graft Substitute Market, Europe, 2013 - 2023 (US$M) 139
  • Figure 5 11: Total Allograft Market, Europe, 2013 - 2023 141
  • Figure 5 12: Units Sold by Country, Total Allograft Market, Europe, 2013 - 2023 143
  • Figure 5 13: Average Selling Price by Country, Total Allograft Market, Europe, 2013 - 2023 (€) 144
  • Figure 5 14: Average Selling Price by Country, Total Allograft Market, Europe, 2013 - 2023 (US$) 145
  • Figure 5 15: Market Value by Country, Total Allograft Market, Europe, 2013 - 2023 (€M) 146
  • Figure 5 16: Market Value by Country, Total Allograft Market, Europe, 2013 - 2023 (US$M) 147
  • Figure 5 17: Total Allograft Spine Market, Europe, 2013 - 2023 148
  • Figure 5 18: Units Sold by Country, Total Allograft Spine Market, Europe, 2013 - 2023 150
  • Figure 5 19: Average Selling Price by Country, Total Allograft Spine Market, Europe, 2013 - 2023 (€) 151
  • Figure 5 20: Average Selling Price by Country, Total Allograft Spine Market, Europe, 2013 - 2023 (US$) 152
  • Figure 5 21: Market Value by Country, Total Allograft Spine Market, Europe, 2013 - 2023 (€M) 153
  • Figure 5 22: Market Value by Country, Total Allograft Spine Market, Europe, 2013 - 2023 (US$M) 154
  • Figure 5 23: Allograft Cervical Spine Market, Europe, 2013 - 2023 155
  • Figure 5 24: Units Sold by Country, Allograft Cervical Spine Market, Europe, 2013 - 2023 157
  • Figure 5 25: Average Selling Price by Country, Allograft Cervical Spine Market, Europe, 2013 - 2023 (€) 158
  • Figure 5 26: Average Selling Price by Country, Allograft Cervical Spine Market, Europe, 2013 - 2023 (US$) 159
  • Figure 5 27: Market Value by Country, Allograft Cervical Spine Market, Europe, 2013 - 2023 (€M) 160
  • Figure 5 28: Market Value by Country, Allograft Cervical Spine Market, Europe, 2013 - 2023 (US$M) 161
  • Figure 5 29: Allograft Thoracolumbar Spine Market, Europe., 2013 - 2023 162
  • Figure 5 30: Units Sold by Country, Allograft Thoracolumbar Spine Market, Europe, 2013 - 2023 164
  • Figure 5 31: Average Selling Price by Country, Allograft Thoracolumbar Spine Market, Europe, 2013 - 2023 (€) 165
  • Figure 5 32: Average Selling Price by Country, Allograft Thoracolumbar Spine Market, Europe, 2013 - 2023 (US$) 166
  • Figure 5 33: Market Value by Country, Allograft Thoracolumbar Spine Market, Europe, 2013 - 2023 (€M) 167
  • Figure 5 34: Market Value by Country, Allograft Thoracolumbar Spine Market, Europe, 2013 - 2023 (US$M) 168
  • Figure 5 35: Allograft Trauma and Reconstruction Market, Europe, 2013 - 2023 169
  • Figure 5 36: Units Sold by Country, Allograft Trauma and Reconstruction Market, Europe, 2013 - 2023 171
  • Figure 5 37: Average Selling Price by Country, Allograft Trauma and Reconstruction Market, Europe, 2013 - 2023 (€) 172
  • Figure 5 38: Average Selling Price by Country, Allograft Trauma and Reconstruction Market, Europe, 2013 - 2023 (US$) 173
  • Figure 5 39: Market Value by Country, Allograft Trauma and Reconstruction Market, Europe, 2013 - 2023 (€M) 174
  • Figure 5 40: Market Value by Country, Allograft Trauma and Reconstruction Market, Europe, 2013 - 2023 (US$M) 175
  • Figure 5 41: Allograft Craniomaxillofacial Market, Europe, 2013 - 2023 176
  • Figure 5 42: Units Sold by Country, Allograft Craniomaxillofacial Market, Europe, 2013 - 2023 178
  • Figure 5 43: Average Selling Price by Country, Allograft Craniomaxillofacial Market, Europe, 2013 - 2023 (€) 179
  • Figure 5 44: Average Selling Price by Country, Allograft Craniomaxillofacial Market, Europe, 2013 - 2023 (US$) 180
  • Figure 5 45: Market Value by Country, Allograft Craniomaxillofacial Market, Europe, 2013 - 2023 (€M) 181
  • Figure 5 46: Market Value by Country, Allograft Craniomaxillofacial Market, Europe, 2013 - 2023 (US$M) 182
  • Figure 5 47: Total Synthetic Market, Europe, 2013 - 2023 184
  • Figure 5 48: Units Sold by Country, Total Synthetic Market, Europe, 2013 - 2023 186
  • Figure 5 49: Average Selling Price by Country, Total Synthetic Market, Europe, 2013 - 2023 (€) 187
  • Figure 5 50: Average Selling Price by Country, Total Synthetic Market, Europe, 2013 - 2023 (US$) 188
  • Figure 5 51: Market Value by Country, Total Synthetic Market, Europe, 2013 - 2023 (€M) 189
  • Figure 5 52: Market Value by Country, Total Synthetic Market, Europe, 2013 - 2023 (US$M) 190
  • Figure 5 53: Total Synthetic Spine Market, Europe, 2013 - 2023 191
  • Figure 5 54: Units Sold by Country, Total Synthetic Spine Market, Europe, 2013 - 2023 194
  • Figure 5 55: Average Selling Price by Country, Total Synthetic Spine Market, Europe, 2013 - 2023 (€) 195
  • Figure 5 56: Average Selling Price by Country, Total Synthetic Spine Market, Europe, 2013 - 2023 (US$) 196
  • Figure 5 57: Market Value by Country, Total Synthetic Spine Market, Europe, 2013 - 2023 (€M) 197
  • Figure 5 58: Market Value by Country, Total Synthetic Spine Market, Europe, 2013 - 2023 (US$M) 198
  • Figure 5 59: Synthetic Cervical Spine Market, Europe, 2013 - 2023 199
  • Figure 5 60: Units Sold by Country, Synthetic Cervical Spine Market, Europe, 2013 - 2023 201
  • Figure 5 61: Average Selling Price by Country, Synthetic Cervical Spine Market, Europe, 2013 - 2023 (€) 202
  • Figure 5 62: Average Selling Price by Country, Synthetic Cervical Spine Market, Europe, 2013 - 2023 (US$) 203
  • Figure 5 63: Market Value by Country, Synthetic Cervical Spine Market, Europe, 2013 - 2023 (€M) 204
  • Figure 5 64: Market Value by Country, Synthetic Cervical Spine Market, Europe, 2013 - 2023 (US$M) 205
  • Figure 5 65: Synthetic Thoracolumbar Spine Market, Europe, 2013 - 2023 206
  • Figure 5 66: Units Sold by Country, Synthetic Thoracolumbar Spine Market, Europe, 2013 - 2023 208
  • Figure 5 67: Average Selling Price by Country, Synthetic Thoracolumbar Spine Market, Europe, 2013 - 2023 (€) 209
  • Figure 5 68: Average Selling Price by Country, Synthetic Thoracolumbar Spine Market, Europe, 2013 - 2023 (US$) 210
  • Figure 5 69: Market Value by Country, Synthetic Thoracolumbar Spine Market, Europe, 2013 - 2023 (€M) 211
  • Figure 5 70: Market Value by Country, Synthetic Thoracolumbar Spine Market, Europe, 2013 - 2023 (US$M) 212
  • Figure 5 71: Synthetic Trauma and Reconstruction Market, Europe, 2013 - 2023 213
  • Figure 5 72: Units Sold by Country, Synthetic Trauma and Reconstruction Market, Europe, 2013 - 2023 215
  • Figure 5 73: Average Selling Price by Country, Synthetic Trauma and Reconstruction Market, Europe, 2013 - 2023 (€) 216
  • Figure 5 74: Average Selling Price by Country, Synthetic Trauma and Reconstruction Market, Europe, 2013 - 2023 (US$) 217
  • Figure 5 75: Market Value by Country, Synthetic Trauma and Reconstruction Market, Europe, 2013 - 2023 (€M) 218
  • Figure 5 76: Market Value by Country, Synthetic Trauma and Reconstruction Market, Europe, 2013 - 2023 (US$M) 219
  • Figure 5 77: Synthetic Craniomaxillofacial Market, Europe, 2013 - 2023 220
  • Figure 5 78: Units Sold by Country, Synthetic Craniomaxillofacial Market, Europe, 2013 - 2023 222
  • Figure 5 79: Average Selling Price by Country, Synthetic Craniomaxillofacial Market, Europe, 2013 - 2023 (€) 223
  • Figure 5 80: Average Selling Price by Country, Synthetic Craniomaxillofacial Market, Europe, 2013 - 2023 (US$) 224
  • Figure 5 81: Market Value by Country, Synthetic Craniomaxillofacial Market, Europe, 2013 - 2023 (€M) 225
  • Figure 5 82: Market Value by Country, Synthetic Craniomaxillofacial Market, Europe, 2013 - 2023 (US$M) 226
  • Figure 5 83: Total Demineralized Bone Matrix Market, Europe, 2013 - 2023 228
  • Figure 5 84: Units Sold by Country, Total Demineralized Bone Matrix Market, Europe, 2013 - 2023 230
  • Figure 5 85: Average Selling Price by Country, Total Demineralized Bone Matrix Market, Europe, 2013 - 2023 (€) 231
  • Figure 5 86: Average Selling Price by Country, Total Demineralized Bone Matrix Market, Europe, 2013 - 2023 (US$) 232
  • Figure 5 87: Market Value by Country, Total Demineralized Bone Matrix Market, Europe, 2013 - 2023 (€M) 233
  • Figure 5 88: Market Value by Country, Total Demineralized Bone Matrix Market, Europe, 2013 - 2023 (US$M) 234
  • Figure 5 89: Total Demineralized Bone Matrix Spine Market, Europe, 2013 - 2023 235
  • Figure 5 90: Units Sold by Country, Total Demineralized Bone Matrix Spine Market, Europe, 2013 - 2023 237
  • Figure 5 91: Average Selling Price by Country, Total Demineralized Bone Matrix Spine Market, Europe, 2013 - 2023 (€) 238
  • Figure 5 92: Average Selling Price by Country, Total Demineralized Bone Matrix Spine Market, Europe, 2013 - 2023 (US$) 239
  • Figure 5 93: Market Value by Country, Total Demineralized Bone Matrix Spine Market, Europe, 2013 - 2023 (€M) 240
  • Figure 5 94: Market Value by Country, Total Demineralized Bone Matrix Spine Market, Europe, 2013 - 2023 (US$M) 241
  • Figure 5 95: Demineralized Bone Matrix Cervical Spine Market, Europe, 2013 - 2023 242
  • Figure 5 96: Units Sold by Country, Demineralized Bone Matrix Cervical Spine Market, Europe, 2013 - 2023 244
  • Figure 5 97: Average Selling Price by Country, Demineralized Bone Matrix Cervical Spine Market, Europe, 2013 - 2023 (€) 245
  • Figure 5 98: Average Selling Price by Country, Demineralized Bone Matrix Cervical Spine Market, Europe, 2013 - 2023 (US$) 246
  • Figure 5 99: Market Value by Country, Demineralized Bone Matrix Cervical Spine Market, Europe, 2013 - 2023 (€M) 247
  • Figure 5 100: Market Value by Country, Demineralized Bone Matrix Cervical Spine Market, Europe, 2013 - 2023 (US$M) 248
  • Figure 5 101: Demineralized Bone Matrix Thoracolumbar Spine Market, Europe, 2013 - 2023 249
  • Figure 5 102: Units Sold by Country, Demineralized Bone Matrix Thoracolumbar Spine Market, Europe, 2013 - 2023 251
  • Figure 5 103: Average Selling Price by Country, Demineralized Bone Matrix Thoracolumbar Spine Market, Europe, 2013 - 2023 (€) 252
  • Figure 5 104: Average Selling Price by Country, Demineralized Bone Matrix Thoracolumbar Spine Market, Europe, 2013 - 2023 (US$) 253
  • Figure 5 105: Market Value by Country, Demineralized Bone Matrix Thoracolumbar Spine Market, Europe, 2013 - 2023 (€M) 254
  • Figure 5 106: Market Value by Country, Demineralized Bone Matrix Thoracolumbar Spine Market, Europe, 2013 - 2023 (US$M) 255
  • Figure 5 107: Demineralized Bone Matrix Trauma and Reconstruction Market, Europe, 2013 - 2023 256
  • Figure 5 108: Units Sold by Country, Demineralized Bone Matrix Trauma and Reconstruction Market, Europe, 2013 - 2023 258
  • Figure 5 109: Average Selling Price by Country, Demineralized Bone Matrix Trauma and Reconstruction Market, Europe, 2013 - 2023 (€) 259
  • Figure 5 110: Average Selling Price by Country, Demineralized Bone Matrix Trauma and Reconstruction Market, Europe, 2013 - 2023 (US$) 260
  • Figure 5 111: Market Value by Country, Demineralized Bone Matrix Trauma and Reconstruction Market, Europe, 2013 - 2023 (€M) 261
  • Figure 5 112: Market Value by Country, Demineralized Bone Matrix Trauma and Reconstruction Market, Europe, 2013 - 2023 (US$M) 262
  • Figure 5 113: Demineralized Bone Matrix Craniomaxillofacial Market, Europe, 2013 - 2023 263
  • Figure 5 114: Units Sold by Country, Demineralized Bone Matrix Craniomaxillofacial Market, Europe, 2013 - 2023 265
  • Figure 5 115: Average Selling Price by Country, Demineralized Bone Matrix Craniomaxillofacial Market, Europe, 2013 - 2023 (€) 266
  • Figure 5 116: Average Selling Price by Country, Demineralized Bone Matrix Craniomaxillofacial Market, Europe, 2013 - 2023 (US$) 267
  • Figure 5 117: Market Value by Country, Demineralized Bone Matrix Craniomaxillofacial Market, Europe, 2013 - 2023 (€M) 268
  • Figure 5 118: Market Value by Country, Demineralized Bone Matrix Craniomaxillofacial Market, Europe, 2013 - 2023 (US$M) 269
  • Figure 5 119: Drivers and Limiters, Bone Graft Substitute Market, Europe, 2016 272
  • Figure 5 120: Leading Competitors, Bone Graft Substitute Market, Europe, 2016 277
  • Figure 6 1: Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2013 - 2023 (€M) 283
  • Figure 6 2: Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2013 - 2023 (US$M) 283
  • Figure 6 3: Total Hyaluronic Acid Viscosupplementation Market, Europe, 2013 - 2023 287
  • Figure 6 4: Units Sold by Country, Total Hyaluronic Acid Viscosupplementation Market, Europe, 2013 - 2023 289
  • Figure 6 5: Average Selling Price by Country, Total Hyaluronic Acid Viscosupplementation Market, Europe, 2013 - 2023 (€) 290
  • Figure 6 6: Average Selling Price by Country, Total Hyaluronic Acid Viscosupplementation Market, Europe, 2013 - 2023 (US$) 291
  • Figure 6 7: Market Value by Country, Total Hyaluronic Acid Viscosupplementation Market, Europe, 2013 - 2023 (€M) 292
  • Figure 6 8: Market Value by Country, Total Hyaluronic Acid Viscosupplementation Market, Europe, 2013 - 2023 (US$M) 293
  • Figure 6 9: Single-Injection Market, Europe, 2013 - 2023 294
  • Figure 6 10: Units Sold by Country, Single-Injection Market, Europe, 2013 - 2023 297
  • Figure 6 11: Average Selling Price by Country, Single-Injection Market, Europe, 2013 - 2023 (€) 298
  • Figure 6 12: Average Selling Price by Country, Single-Injection Market, Europe, 2013 - 2023 (US$) 299
  • Figure 6 13: Market Value by Country, Single-Injection Market, Europe, 2013 - 2023 (€M) 300
  • Figure 6 14: Market Value by Country, Single-Injection Market, Europe, 2013 - 2023 (US$M) 301
  • Figure 6 15: Three-Injection Market, Europe, 2013 - 2023 302
  • Figure 6 16: Units Sold by Country, Three-Injection Market, Europe, 2013 - 2023 305
  • Figure 6 17: Average Selling Price by Country, Three-Injection Market, Europe, 2013 - 2023 (€) 306
  • Figure 6 18: Average Selling Price by Country, Three-Injection Market, Europe, 2013 - 2023 (US$) 307
  • Figure 6 19: Market Value by Country, Three-Injection Market, Europe, 2013 - 2023 (€M) 308
  • Figure 6 20: Market Value by Country, Three-Injection Market, Europe, 2013 - 2023 (US$M) 309
  • Figure 6 21: Five-Injection Market, Europe, 2013 - 2023 310
  • Figure 6 22: Units Sold by Country, Five-Injection Market, Europe, 2013 - 2023 313
  • Figure 6 23: Average Selling Price by Country, Five-Injection Market, Europe, 2013 - 2023 (€) 314
  • Figure 6 24: Average Selling Price by Country, Five-Injection Market, Europe, 2013 - 2023 (US$) 315
  • Figure 6 25: Market Value by Country, Five-Injection Market, Europe, 2013 - 2023 (€M) 316
  • Figure 6 26: Market Value by Country, Five-Injection Market, Europe, 2013 - 2023 (US$M) 317
  • Figure 6 27: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, Europe, 2016 320
  • Figure 6 28: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Europe, 2016 323
  • Figure 7 1: Bone Morphogenetic Protein Growth Factor Therapy Market, Europe, 2013 - 2023 327
  • Figure 7 2: Units Sold by Country, Bone Morphogenetic Protein Growth Factor Therapy Market, Europe, 2013 - 2023 330
  • Figure 7 3: Average Selling Price by Country, Bone Morphogenetic Protein Growth Factor Therapy Market, Europe, 2013 - 2023 (€) 331
  • Figure 7 4: Average Selling Price by Country, Bone Morphogenetic Protein Growth Factor Therapy Market, Europe, 2013 - 2023 (US$) 332
  • Figure 7 5: Market Value by Country, Bone Morphogenetic Protein Growth Factor Therapy Market, Europe, 2013 - 2023 (€M) 333
  • Figure 7 6: Market Value by Country, Bone Morphogenetic Protein Growth Factor Therapy Market, Europe, 2013 - 2023 (US$M) 334
  • Figure 7 7: Drivers and Limiters, Bone Morphogenetic Protein Growth Factor Therapy Market, Europe, 2016 336
  • Figure 7 8: Leading Competitors, Bone Morphogenetic Protein Growth Factor Therapy Market, Europe 2016 337
  • Figure 8 1: Autologous Chondrocyte Implantation Market, Europe, 2013 - 2023 343
  • Figure 8 2: Units Sold by Country, Autologous Chondrocyte Implantation Market, Europe, 2013 - 2023 346
  • Figure 8 3: Average Selling Price by Country, Autologous Chondrocyte Implantation Market, Europe, 2013 - 2023 (€) 347
  • Figure 8 4: Average Selling Price by Country, Autologous Chondrocyte Implantation Market, Europe, 2013 - 2023 (US$) 348
  • Figure 8 5: Market Value by Country, Autologous Chondrocyte Implantation Market, Europe, 2013 - 2023 (€M) 349
  • Figure 8 6: Market Value by Country, Autologous Chondrocyte Implantation Market, Europe, 2013 - 2023 (US$M) 350
  • Figure 8 7: Drivers and Limiters, Autologous Chondrocyte Implantation Market, Europe, 2016 352
  • Figure 8 8: Leading Competitors, Autologous Chondrocyte Implantation Market, Europe 2016 354
  • Figure 9 1: Orthopedic Cell Therapy Market by Segment, Europe, 2013 - 2023 (€M) 362
  • Figure 9 2: Orthopedic Cell Therapy Market by Segment, Europe, 2013 - 2023 (US$M) 362
  • Figure 9 3: Total Orthopedic Cell Therapy Market, Europe, 2013 - 2023 365
  • Figure 9 4: Units Sold by Country, Total Orthopedic Cell Therapy Market, Europe, 2013 - 2023 367
  • Figure 9 5: Average Selling Price by Country, Total Orthopedic Cell Therapy Market, Europe, 2013 - 2023 (€) 368
  • Figure 9 6: Average Selling Price by Country, Total Orthopedic Cell Therapy Market, Europe, 2013 - 2023 (US$) 369
  • Figure 9 7: Market Value by Country, Total Orthopedic Cell Therapy Market, Europe, 2013 - 2023 (€M) 370
  • Figure 9 8: Market Value by Country, Total Orthopedic Cell Therapy Market, Europe, 2013 - 2023 (US$M) 371
  • Figure 9 9: Total Platelet-Rich Plasma Market, Europe, 2013 - 2023 372
  • Figure 9 10: Units Sold by Country, Platelet-Rich Plasma Market, Europe, 2013 - 2023 374
  • Figure 9 11: Average Selling Price by Country, Total Platelet-Rich Plasma Market, Europe, 2013 - 2023 (€) 375
  • Figure 9 12: Average Selling Price by Country, Total Platelet-Rich Plasma Market, Europe, 2013 - 2023 (US$) 376
  • Figure 9 13: Market Value by Country, Total Platelet-Rich Plasma Market, Europe, 2013 - 2023 (€M) 377
  • Figure 9 14: Market Value by Country, Total Platelet-Rich Plasma Market, Europe, 2013 - 2023 (US$M) 378
  • Figure 9 15: Soft Tissue Platelet-Rich Plasma Market, Europe, 2013 - 2023 379
  • Figure 9 16: Units Sold by Country, Soft Tissue Platelet-Rich Plasma Market, Europe, 2013 - 2023 381
  • Figure 9 17: Average Selling Price by Country, Soft Tissue Platelet-Rich Plasma Market, Europe, 2013 - 2023 (€) 382
  • Figure 9 18: Average Selling Price by Country, Soft Tissue Platelet-Rich Plasma Market, Europe, 2013 - 2023 (US$) 383
  • Figure 9 19: Market Value by Country, Soft Tissue Platelet-Rich Plasma Market, Europe, 2013 - 2023 (€M) 384
  • Figure 9 20: Market Value by Country, Soft Tissue Platelet-Rich Plasma Market, Europe, 2013 - 2023 (US$M) 385
  • Figure 9 21: Orthopedic Platelet-Rich Plasma Market, Europe, 2013 - 2023 386
  • Figure 9 22: Units Sold by Country, Orthopedic Platelet-Rich Plasma Market, Europe, 2013 - 2023 388
  • Figure 9 23: Average Selling Price by Country, Orthopedic Platelet-Rich Plasma Market, Europe, 2013 - 2023 (€) 389
  • Figure 9 24: Average Selling Price by Country, Orthopedic Platelet-Rich Plasma Market, Europe, 2013 - 2023 (US$) 390
  • Figure 9 25: Market Value by Country, Orthopedic Platelet-Rich Plasma Market, Europe, 2013 - 2023 (€M) 391
  • Figure 9 26: Market Value by Country, Orthopedic Platelet-Rich Plasma Market, Europe, 2013 - 2023 (US$M) 392
  • Figure 9 27: Cardiac Platelet-Rich Plasma Market, Europe, 2013 - 2023 393
  • Figure 9 28: Units Sold by Country, Cardiac Platelet-Rich Plasma Market, Europe, 2013 - 2023 395
  • Figure 9 29: Average Selling Price by Country, Cardiac Platelet-Rich Plasma Market, Europe, 2013 - 2023 (€) 396
  • Figure 9 30: Average Selling Price by Country, Cardiac Platelet-Rich Plasma Market, Europe, 2013 - 2023 (US$) 397
  • Figure 9 31: Market Value by Country, Cardiac Platelet-Rich Plasma Market, Europe, 2013 - 2023 (€M) 398
  • Figure 9 32: Market Value by Country, Cardiac Platelet-Rich Plasma Market, Europe, 2013 - 2023 (US$M) 399
  • Figure 9 33: Spine Platelet-Rich Plasma Market, Europe, 2013 - 2023 400
  • Figure 9 34: Units Sold by Country, Spine Platelet-Rich Plasma Market, Europe, 2013 - 2023 402
  • Figure 9 35: Average Selling Price by Country, Spine Platelet-Rich Plasma Market, Europe, 2013 - 2023 (€) 403
  • Figure 9 36: Average Selling Price by Country, Spine Platelet-Rich Plasma Market, Europe, 2013 - 2023 (US$) 404
  • Figure 9 37: Market Value by Country, Spine Platelet-Rich Plasma Market, Europe, 2013 - 2023 (€M) 405
  • Figure 9 38: Market Value by Country, Spine Platelet-Rich Plasma Market, Europe, 2013 - 2023 (US$M) 406
  • Figure 9 39: Plastics Platelet-Rich Plasma Market, Europe, 2013 - 2023 407
  • Figure 9 40: Units Sold by Country, Plastics Platelet-Rich Plasma Market, Europe, 2013 - 2023 409
  • Figure 9 41: Average Selling Price by Country, Plastics Platelet-Rich Plasma Market, Europe, 2013 - 2023 (€) 410
  • Figure 9 42: Average Selling Price by Country, Plastics Platelet-Rich Plasma Market, Europe, 2013 - 2023 (US$) 411
  • Figure 9 43: Market Value by Country, Plastics Platelet-Rich Plasma Market, Europe, 2013 - 2023 (€M) 412
  • Figure 9 44: Market Value by Country, Plastics Platelet-Rich Plasma Market, Europe, 2013 - 2023 (US$M) 413
  • Figure 9 45: Total Bone Marrow Concentrate Market, Europe, 2013 - 2023 414
  • Figure 9 46: Units Sold by Country, Total Bone Marrow Concentrate Market, Europe, 2013 - 2023 416
  • Figure 9 47: Average Selling Price by Country, Total Bone Marrow Concentrate Market, Europe, 2013 - 2023 (€) 417
  • Figure 9 48: Average Selling Price by Country, Total Bone Marrow Concentrate Market, Europe, 2013 - 2023 (US$) 418
  • Figure 9 49: Market Value by Country, Total Bone Marrow Concentrate Market, Europe, 2013 - 2023 (€M) 419
  • Figure 9 50: Market Value by Country, Total Bone Marrow Concentrate Market, Europe, 2013 - 2023 (US$M) 420
  • Figure 9 51: Spine Bone Marrow Concentrate Market, Europe, 2013 - 2023 421
  • Figure 9 52: Units Sold by Country, Spine Bone Marrow Concentrate Market, Europe, 2013 - 2023 423
  • Figure 9 53: Average Selling Price by Country, Spine Bone Marrow Concentrate Market, Europe, 2013 - 2023 (€) 424
  • Figure 9 54: Average Selling Price by Country, Spine Bone Marrow Concentrate Market, Europe, 2013 - 2023 (US$) 425
  • Figure 9 55: Market Value by Country, Spine Bone Marrow Concentrate Market, Europe, 2013 - 2023 (€M) 426
  • Figure 9 56: Market Value by Country, Spine Bone Marrow Concentrate Market, Europe, 2013 - 2023 (US$M) 427
  • Figure 9 57: Trauma Bone Marrow Concentrate Market, Europe, 2013 - 2023 428
  • Figure 9 58: Units Sold by Country, Trauma Bone Marrow Concentrate Market, Europe, 2013 - 2023 430
  • Figure 9 59: Average Selling Price by Country, Trauma Bone Marrow Concentrate Market, Europe, 2013 - 2023 (€) 431
  • Figure 9 60: Average Selling Price by Country, Trauma Bone Marrow Concentrate Market, Europe, 2013 - 2023 (US$) 432
  • Figure 9 61: Market Value by Country, Trauma Bone Marrow Concentrate Market, Europe, 2013 - 2023 (€M) 433
  • Figure 9 62: Market Value by Country, Trauma Bone Marrow Concentrate Market, Europe, 2013 - 2023 (US$M) 434
  • Figure 9 63: Soft Tissue Concentrated Bone Marrow Aspirate Market, Europe, 2013 - 2023 435
  • Figure 9 64: Units Sold by Country, Soft Tissue Concentrated Bone Marrow Aspirate Market, Europe, 2013 - 2023 437
  • Figure 9 65: Average Selling Price by Country, Soft Tissue Concentrated Bone Marrow Aspirate Market, Europe, 2013 - 2023 (€) 438
  • Figure 9 66: Average Selling Price by Country, Soft Tissue Concentrated Bone Marrow Aspirate Market, Europe, 2013 - 2023 (US$) 439
  • Figure 9 67: Market Value by Country, Soft Tissue Concentrated Bone Marrow Aspirate Market, Europe, 2013 - 2023 (€M) 440
  • Figure 9 68: Market Value by Country, Soft Tissue Concentrated Bone Marrow Aspirate Market, Europe, 2013 - 2023 (US$M) 441
  • Figure 9 69: Joint Concentration Bone Marrow Concentrate Market, Europe, 2013 - 2023 442
  • Figure 9 70: Units Sold by Country, Joint Concentration Bone Marrow Concentrate Market, Europe, 2013 - 2023 444
  • Figure 9 71: Average Selling Price by Country, Joint Concentration Bone Marrow Concentrate Market, Europe, 2013 - 2023 (€) 445
  • Figure 9 72: Average Selling Price by Country, Joint Concentration Bone Marrow Concentrate Market, Europe, 2013 - 2023 (US$) 446
  • Figure 9 73: Market Value by Country, Joint Concentration Bone Marrow Concentrate Market, Europe, 2013 - 2023 (€M) 447
  • Figure 9 74: Market Value by Country, Joint Concentration Bone Marrow Concentrate Market, Europe, 2013 - 2023 (US$M) 448
  • Figure 9 75: Drivers and Limiters, Orthopedic Cell Therapy Market, Europe, 2016 450
  • Figure 9 76: Leading Competitors, Orthopedic Cell Therapy Market, Europe, 2016 453
Back to Top